Fund moves

ANI Pharmaceuticals, Inc. (ANIP)Divisadero Street Capital Management, LP opened a new position $21.5M

Divisadero Street Capital Management, LP opened a new position in ANI Pharmaceuticals, Inc., per its Q3 2025 13F.

234K
Shares reported
0.94%
Disclosed portfolio weight
$21.5M
Reported value
Holdings as of
Sep 30, 2025
Filed
Nov 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 12, 2025InsiderOfficer sold ~$39K of ANIP shares in the open market
  2. Sep 19, 2025InsiderOfficer sold ~$98K of ANIP shares in the open market
  3. Sep 26, 2025Company filing · Form 8-K · Unregistered shares, Shareholder rightsSold new shares without registering them, and changed the rights of its shareholders
  4. Nov 7, 2025Company filing · Form 8-K · ResultsReported its results
  5. Nov 10, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors

What came next

  1. Nov 24, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On November 24, 2025, Patrick D. Walsh notified the Company that he will not seek re-election as a director at the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”), but will continue to serve as a director until the Annual Meeting.”
  2. Jan 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  3. Feb 27, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for ANI Pharmaceuticals, Inc.

For ANI Pharmaceuticals, Inc., OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ANIP page.

How this filing works

Other disclosures at ANI Pharmaceuticals, Inc.

Everything OQRO holds on this company is on its ANIP page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data